Optimize Asthma Prior Authorization Workflows with Klivira
Navigating the complexities of asthma prior authorization for high-cost biologics and specialty medications presents a significant administrative burden for health systems. Klivira automates these critical processes, ensuring timely approvals and reducing operational overhead.
Asthma management often involves medications and diagnostics subject to prior authorization, leading to potential delays in care and increased administrative costs. For revenue cycle directors and prior authorization coordinators, efficient processing is paramount to maintaining patient access and financial health. Klivira provides a robust solution designed to address these specific challenges.
The Administrative Burden of Asthma Prior Authorization
Asthma treatment pathways, especially those involving advanced therapies like biologics, frequently trigger prior authorization requirements. This introduces significant administrative overhead, demanding extensive manual documentation, portal navigation, and follow-up, which strains resources and can delay essential patient care.
Common Challenges in Asthma PA Management
- Manual data entry across disparate payer portals and EMRs.
- Complex clinical documentation requirements for specialty asthma medications.
- Tracking expiration dates and managing recurring authorizations.
- Varied payer rules and submission formats (e.g., X12 278, proprietary portals).
- High denial rates due to incomplete submissions or missed deadlines.
Klivira's Strategic Approach to Asthma PA Automation
Klivira leverages intelligent automation to streamline the entire asthma prior authorization lifecycle. By integrating directly with your EMR and payer systems, our platform automates data extraction, form submission, and status tracking, reducing manual effort and improving submission accuracy.
Key Capabilities for Asthma Prior Authorization
- Automated submission of X12 278 and ePA requests for asthma medications.
- SMART on FHIR integration for seamless data exchange with EMRs.
- Real-time status tracking and proactive alerts for asthma PA approvals or denials.
- Centralized dashboard for managing all asthma-related prior authorizations.
- Support for Da Vinci PAS implementation for standardized PA workflows.
Enhancing Patient Access and Operational Efficiency
By automating asthma prior authorization, Klivira helps health systems accelerate patient access to critical therapies while simultaneously reducing administrative costs. Our platform minimizes the potential for human error and ensures that clinical teams can focus on patient care rather than administrative tasks.
Frequently asked questions
Which types of asthma treatments does Klivira support for prior authorization?
Klivira supports prior authorization for a broad range of asthma treatments, including specialty biologics (e.g., monoclonal antibodies), high-cost inhaled corticosteroids, and associated diagnostic procedures. Our platform is configurable to specific payer and medication requirements.
How does Klivira integrate with our existing EMR for asthma prior authorizations?
Klivira integrates with major EMR systems using industry standards like SMART on FHIR. This allows for automated extraction of necessary clinical documentation and patient demographics directly from the EMR, populating prior authorization requests without manual transcription.
Can Klivira manage recurring prior authorizations for chronic asthma conditions?
Yes, Klivira provides robust features for managing recurring prior authorizations. Our system tracks approval expiration dates and can initiate renewal processes proactively, ensuring continuous coverage for patients with chronic asthma conditions.
What is Klivira's role in supporting compliance for asthma prior authorizations?
Klivira's platform is designed to support compliance by ensuring accurate, timely, and complete submission of prior authorization requests according to payer rules and evolving standards like CMS-0057-F. We provide a clear audit trail for all PA activities, which can be valuable for internal compliance reviews.
Related coverage
Ready to automate prior auth for this condition?
See how Klivira automates prior authorizations for your team.
Request a demo